Download PDF
CC BY 4.0 · TH Open 2022; 06(03): e213-e220
DOI: 10.1055/a-1827-7025
Original Article

Influencing Factors and Differences in Born Aggregometry in Specialized Hemostaseological Centers: Results of a Multicenter Laboratory Comparison

Thorsten Kaiser
1   Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University of Leipzig, Paul-List-Str., Leipzig, Germany
,
Karin Liebscher
2   Institute of Transfusion Medicine and Clinical Hemostaseology, Klinikum St. Georg gGmbH, Delitzscher Straße, Leipzig, Germany
,
Ute Scholz
3   MVZ Laboratory Reising-Ackermann MD and Colleagues, Strümpellstraße, Leipzig, Germany
,
Christian Pfrepper 
4   Division of Hemostaseology, University Hospital Leipzig, Liebigstraße, Leipzig, Germany
,
Jeffrey Netto 
1   Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University of Leipzig, Paul-List-Str., Leipzig, Germany
,
Tim Drogies
5   Medical Central Laboratory Altenburg, Am Waldessaum, Altenburg, Germany
,
Oliver Tiebel
6   Institute of Clinical Chemistry and Laboratory Medicine, Medical Faculty of Technical University, Dresden, Germany
,
Ralf Knöfler
7   Department of Paediatric Haemostaseology, University Hospital Carl Gustav Carus, Dresden, Germany
,
Michael Krause
3   MVZ Laboratory Reising-Ackermann MD and Colleagues, Strümpellstraße, Leipzig, Germany
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Introduction Light transmission aggregometry (LTA) is regarded as the gold standard in platelet function diagnostics. However, there is a relevant degree of interlaboratory variability in practical applications.

Objective The aim of the present study was to develop a practicable laboratory comparison on LTA and to analyze differences and influencing factors in regard to standardization in five specialized hemostaseological centers.

Methods The study was performed on 30 patients in total. Each center performed LTA on blood samples from six healthy volunteers (three men and three women) using the inductors collagen (Col), adenosine diphosphate (ADP), arachidonic acid (ARA), and ristocetin. The LTA was performed three times using different methods as follows: (1) International Society on Thrombosis and Haemostasis recommendations with identical reagents, (2) in-house protocols and the identical reagents; and (3) in-house protocols and in-house reagents.

Results A total of 396 measurements of 30 probands were performed. Even after standardization of the protocol and using identical reagents, there were significant differences between the centers regarding the final and maximum aggregation (p = 0.002 and <0.001) and further significant differences in the maximum and final aggregation according to the wavelength of the device used to measure the LTA (PAP-8: 430 nm, APACT 4004: 740 nm [p < 0.001 each]). Using identical reagents but individual inductor concentrations and laboratory protocols also resulted in different maximum and final aggregation. The largest differences were seen with Col and ristocetin; there were significant influences from the reagents' manufacturers in the results of aggregometry for the inductor Col (p < 0.01) but not for ADP, ARA, and ristocetin.

Conclusion In this study, we proved that there are significant influences from the used aggregometers, inductors concentrations, and manufacturers. These results illustrate the challenges and importance of standardization of LTA.

Keywords

inherited/acquired platelet disorders - platelet physiology - platelet immunology - platelet glycoproteins


Publication History

Received: 24 November 2021

Accepted: 14 February 2022

Accepted Manuscript online:
18 April 2022

Article published online:
22 August 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-929
    CrossrefPubMedGoogle Scholar
  • 2 Born GV, Cross MJ. The aggregation of blood platelets. J Physiol 1963; 168: 178-195
    CrossrefPubMedGoogle Scholar
  • 3 Born GV. Light on platelets. J Physiol 2005; 568 (pt. 3): 713-714
    CrossrefPubMedGoogle Scholar
  • 4 O'brien RJ. Some effects of adrenaline and anti-adrenaline compounds on platelets in vitro and in vivo. Nature 1963; 200: 763-764
    CrossrefPubMedGoogle Scholar
  • 5 Budde U. diagnose von funktionsstörungen der thrombozyten mit hilfe der aggregometrie/diagnosis of platelet function defects with platelet aggregometers. Laboratoriumsmedizin (Berl) 2005; 26: 564-571
    PubMedGoogle Scholar
  • 6 Chan MV, Armstrong PC, Warner TD. 96-well plate-based aggregometry. Platelets 2018; 29 (07) 650-655
    CrossrefPubMedGoogle Scholar
  • 7 Krekels JPM, Verhezen PWM, Henskens YMC. Platelet aggregation in healthy participants is not affected by smoking, drinking coffee, consuming a high-fat meal, or performing physical exercise. Clin Appl Thromb Hemost 2019; 25: 1076029618782445
    CrossrefPubMedGoogle Scholar
  • 8 Cattaneo M, Cerletti C, Harrison P. et al. Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the Platelet Physiology Subcommittee of SSC/ISTH. J Thromb Haemost 2013; 11: 1183-1189
    CrossrefPubMedGoogle Scholar
  • 9 Knöfler R, Eberl W, Schulze H. et al. [Diagnosis of inherited diseases of platelet function. Interdisciplinary S2K guideline of the Permanent Paediatric Committee of the Society of Thrombosis and Haemostasis Research (GTH e. V.)]. Hamostaseologie 2014; 34 (03) 201-212
    PubMedGoogle Scholar
  • 10 Harrison P, Mackie I, Mumford A. et al; British Committee for Standards in Haematology. Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol 2011; 155 (01) 30-44
    CrossrefPubMedGoogle Scholar
  • 11 Gresele P. Subcommittee on Platelet Physiology of the International Society on Thrombosis and Hemostasis. Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost 2015; 13 (02) 314-322 DOI: 10.1111/jth.12792.
    CrossrefPubMedGoogle Scholar
  • 12 Streif W, Oliveri M, Weickardt S, Eberl W, Knoefler R. Thromkid Study Group of GTH. Testing for inherited platelet defects in clinical laboratories in Germany, Austria and Switzerland. Results of a survey carried out by the Permanent Paediatric Group of the German Thrombosis and Haemostasis Research Society (GTH). Platelets 2010; 21 (06) 470-478
    CrossrefPubMedGoogle Scholar
  • 13 Cattaneo M, Hayward CP, Moffat KA, Pugliano MT, Liu Y, Michelson AD. Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH. J Thromb Haemost 2009; 7 (06) 1029
    CrossrefPubMedGoogle Scholar
  • 14 Moffat KA, Ledford-Kraemer MR, Nichols WL, Hayward CP. North American Specialized Coagulation Laboratory Association. Variability in clinical laboratory practice in testing for disorders of platelet function: results of two surveys of the North American Specialized Coagulation Laboratory Association. Thromb Haemost 2005; 93 (03) 549-553
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Diagnose von Thrombozytenfunktionsstörungen-Thrombozytopathien. Accessed April 27, 2022 at: https://www.awmf.org/uploads/tx_szleitlinien/086-003l_S2k_Diagnostik_Thrombozytenfunktionsstoerungen_Thrombozytopathien_2018-09.pdf
    Google Scholar
  • 16 Koltai K, Kesmarky G, Feher G, Tibold A, Toth K. Platelet aggregometry testing: molecular mechanisms, techniques and clinical implications. Int J Mol Sci 2017; 18 (08) E1803
    CrossrefPubMedGoogle Scholar
  • 17 Paniccia R, Priora R, Liotta AA, Abbate R. Platelet function tests: a comparative review. Vasc Health Risk Manag 2015; 11: 133-148
    CrossrefPubMedGoogle Scholar
  • 18 Linnemann B, Schwonberg J, Mani H, Prochnow S, Lindhoff-Last E. Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary. J Thromb Haemost 2008; 6 (04) 677-683
    CrossrefPubMedGoogle Scholar
  • 19 Hayward CPM, Moffat KA, Raby A. et al. Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry. Am J Clin Pathol 2010; 134 (06) 955-963
    CrossrefPubMedGoogle Scholar
  • 20 Braun S. Gepaarte Studie zur Validierung des neuen Thrombozytenaggregometers PAP-8 und zur Untersuchung des Einflusses der Einstellung der Thrombozytenkonzentration des plättchenreichen Plasmas auf die Ergebnisse der Thrombozytenaggregationstestung mit PAP-8 und PAP-4 [Dissertation]. Nuremberg, Germany: : University of Erlangen, 2012
    Google Scholar
  • 21 Farndale R, Siljander RPM. Collagen-induced platelet activation. In: Arnout J, de Gaetano G, Hoylarts M, Peerlinck K, Van Geet C, Verhaegle R. ., eds. Thrombosis – Fundamental and clinical aspects. Leuven, Belgium: Leuven University Press; 2003
    Google Scholar
  • 22 Guidetti G, Bertoni A, Viola M, Tira E, Balduini C, Torti M. The small proteoglycan decorin supports adhesion and activation of human platelets. Blood 2002; 100 (05) 1707-1714
    CrossrefPubMedGoogle Scholar
  • 23 Rolf N, Knoefler R, Bugert P. et al. Clinical and laboratory phenotypes associated with the aspirin-like defect: a study in 17 unrelated families. Br J Haematol 2009; 144 (03) 416-424
    CrossrefPubMedGoogle Scholar